Recurrent Endometrial Adenocarcinoma
2 clinical trials · Condition
◉ Watch Recurrent Endometrial Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer (NCT03914612) | National Cancer Institute (NCI) | 2019-08-22 |
| VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer (NCT03120624) | Mayo Clinic | 2017-09-15 |
Track Recurrent Endometrial Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.